To explore the consistency between result of PTC drug screening tests and actual clinical outcome for patients with advanced malignancy.
18 to 75 years old, regardless of gender.
Score of nutrition risk screening 2002 (NRS2002) is less than 3, NRS20023.
Advanced and unresectable malignancy confirmed by biopsy diagnosis.
Able to tolerate anti-tumor treatment, and without serious cardiopulmonary and other underlying diseases.
Pregnant or lactating women.
Have Participated other clinical trials in six months.
Severe liver dysfunction.
Severe renal dysfunction.